Live from the NIH registry
Studies recruiting near Deltona right now
Top 25 of 978 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
AdventHealth Orlando — Orlando, Florida (27.2 mi)
· Sponsor: Syndax Pharmaceuticals
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
Helicobacter Pylori, Safety
Phase 3
Interventional 40 participants sought
Orlando Health, Inc. — Orlando, Florida (27.2 mi)
· Sponsor: ARJ Medical, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Advanced Urology Institute - Daytona Beach — Daytona Beach, Florida (24.1 mi)
· Sponsor: Pacific Edge Limited
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Research Institute of Orlando, LLC — Orlando, Florida (27.2 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
AdventHealth — Orlando, Florida (27.2 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Local Institution - 0126 — Orlando, Florida (27.2 mi)
· Sponsor: Bristol-Myers Squibb
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
Central Florida Pulmonary Group — Orlando, Florida (27.2 mi)
· Sponsor: Anagram Therapeutics, Inc.
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Orlando — Maitland, Florida (21.2 mi)
· Sponsor: RAI Services Company
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Small Cell Lung Cancer
Phase 3
Interventional 400 participants sought
University of Florida Health Cancer Center at Orlando Health — Orlando, Florida (27.2 mi)
· Sponsor: Amgen
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Advent Health Orlando — Orlando, Florida (27.2 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
CTR Oakwater LLC — Orlando, Florida (27.2 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: Giselle Sholler
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - North — Orange City, Florida (6.0 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263 — Winter Park, Florida (22.4 mi)
· Sponsor: AbbVie
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
AdventHealth — Orlando, Florida (27.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Orlando, Florida (27.2 mi)
· Sponsor: Sameek Roychowdhury
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
Phase 2
Interventional 160 participants sought
Advent Health Medical Group Urology — Orlando, Florida (27.2 mi)
· Sponsor: ImmVira Pharma Co. Ltd
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Orange City, Florida (6.0 mi)
· Sponsor: Daiichi Sankyo
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
AdventHealth Orlando — Orlando, Florida (27.2 mi)
· Sponsor: Eli Lilly and Company
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU — DeLand, Florida (10.1 mi)
· Sponsor: Annovis Bio Inc.
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
Ovarian Cancer, Peritoneal Cancer
Phase 3
Interventional 646 participants sought
Orlando Health Cancer Institute ( Site 0018) — Orlando, Florida (27.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Clinical Neuroscience Solutions — Orlando, Florida (27.2 mi)
· Sponsor: Alveus Therapeutics, Inc.
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Acute Myeloid Leukemia
Phase 2
Interventional 53 participants sought
AdventHealth Orlando — Orlando, Florida (27.2 mi)
· Sponsor: Joshua Zeidner
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: Giselle Sholler